Novo Nordisk has launched a higher-dose version of its weight-loss drug Wegovy in the US, priced at $399 per month for cash payers, alongside a discounted subscription plan to compete with Eli Lilly.
Metformin, a widely prescribed diabetes medication, has been found to raise levels of a key exercise-related molecule, potentially aiding weight control and heart health in inactive patients.
Health and wellness brand Applied Nutrition is launching new GLP-1 specific products to cater to the growing market of weight loss drug users, capitalizing on demand for supplements and smaller portions.
Applied Nutrition is launching new products tailored for GLP-1 weight-loss jab users, capitalising on rising demand as over 1.6 million Britons use such treatments.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
The experimental weight loss drug Retatrutide is raising alarms as reports emerge of users experiencing emotional blunting and reduced romantic feelings, prompting calls for further research.
Lord Vallance highlights the UK's new US-UK pharmaceutical trade deal, stressing that patients must access treatments quickly to turn scientific triumphs into real health benefits.
The FDA has granted expedited approval to Eli Lilly's Foundayo, a daily oral weight-loss pill, as part of a new programme to cut drug approval times. The drug, orforglipron, offers an alternative to injectable GLP-1 medications.
Over 3.1 million bottles of eye drops are being recalled in the US due to sterility concerns, affecting brands sold at CVS, Walgreens, and other major retailers. The FDA has classified it as a Class II recall, advising consumers to discard or return produ
Over 3.1 million bottles of eye drops sold at CVS, Walgreens, and other major retailers are recalled due to sterility concerns. The FDA classifies it as a Class II recall.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
K.C. Pharmaceuticals has recalled over 3 million bottles of generic eye drops nationwide due to a lack of assurance of sterility, posing potential vision risks.
A new UK-US medicines agreement exempts British drug exports from US tariffs but critics warn it could cost the NHS billions by increasing drug prices and lacks parliamentary scrutiny.
Health Minister Mark Butler declares Australia will not remove consumer price protections on medications despite pressure from pharmaceutical giants and Trump's new 100% tariff on US drug imports.
Federal authorities have arrested eight individuals in Southern California for alleged healthcare fraud schemes totaling $50 million, focusing on hospice care centers and union plan fraud.
President Donald Trump has announced 100% tariffs on prescription drugs from overseas companies that haven't agreed to lower prices, marking the anniversary of his 'Liberation Day' trade policies.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
The FDA has granted expedited approval to Eli Lilly's Foundayo, a new oral weight-loss medication. This article details its cost, how it compares to injectables like Zepbound, and its clinical trial results.
Eswatini, with the world's highest HIV prevalence, rolls out lenacapavir, a six-monthly injection to prevent infections. However, limited doses and funding cuts threaten its potential impact.
The FDA has approved Eli Lilly's Foundayo, a once-daily GLP-1 pill for weight loss, expanding access to oral treatments and competing with Novo Nordisk's Wegovy.
U.S. regulators have granted expedited approval to Eli Lilly's new oral weight-loss medication, Foundayo, offering a convenient alternative to injectable GLP-1 drugs for treating obesity.
NHS England head Jim Mackey expresses deep concern over potential medicine supply disruptions linked to the Iran conflict, with some stocks lasting only days.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Novo Nordisk introduces a discounted subscription plan for Wegovy, offering up to 29% off for self-funding US patients via telehealth platforms to boost access and market share.
Novo Nordisk launches discounted Wegovy subscription plan for US self-pay patients, offering up to 30% savings through telehealth platforms to compete with Eli Lilly's Zepbound.
US pharmaceutical giant Eli Lilly, maker of Mounjaro, will only unpause its UK investments if ministers agree to regular NHS drug price increases and end a rebate scheme. Talks are ongoing, with the company optimistic about a summer agreement.
Gear Isle recalls Gold Lion and ilum Sex Chocolate after FDA finds sildenafil and tadalafil, posing life-threatening blood pressure risks.
Experts warn Britain could see shortages of essential medicines, from painkillers to cancer treatments, in a few weeks if the Iran war persists, with rising drug prices likely due to air and sea transport disruptions.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
A widow describes how her husband developed compulsive sexual behaviour overnight after taking Pramipexole, a Parkinson's medication, with warnings labelled 'uncommon' despite studies showing 17% risk.
Dietary supplement companies are urging the FDA to broaden ingredient criteria, potentially enabling peptides and probiotics in products, amid industry pressure and regulatory uncertainty.
A recent phase 3 trial reveals orforglipron, a daily oral pill, is more effective for weight loss and blood sugar control than current oral semaglutide, though with higher side-effects.
The FDA has approved Wegovy HD, a triple-dose weight loss injection, with patients losing 21% body weight. Novo Nordisk expands its GLP-1 drug portfolio amid competitive market pressures.
Cheap generic versions of Wegovy weight loss injections are set to become widely available in the UK within months as the drug's patent expires in key countries, raising concerns about unregulated online sales and safety risks.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
The Advertising Standards Authority has prohibited advertisements for five health supplements, including 222 Balance Me and Lunera, for making unsubstantiated claims about treating menopause and PCOS symptoms.
